References
- Ketoprofen, summary of product charcteristics. [https://www.hpra.ie>uploadded>]. (access: 10.12.2023).
- Brandolini L, d’Angelo M, Antonosante A, Villa S, Cristiano L, Castelli V, et al. Differential protein modulation by ketoprofen and ibuprofen underlines different cellular response by gastric epithelium. J Cell Physiol. 2018;233(3):2304-12.
- Cimini A, Brandolini L, Gentile R, Cristiano L, Menghini P, Fidoamore A, et al. Gastroprotective effects of L-lysine salification of ketoprofen in ethanol-injured gastric mucosa. J Cell Physiol. 2015;230(4):813-20.
- Kuczyńska J, Nieradko-Iwanicka B. The effect of ketoprofen lysine salt on mucosa of rat stomach after ethyl alcohol intoxication. Biomed Pharmacother. 2021;141:111938.
- Miyazaki R, Yamamoto T. Sex and/or gender differences in pain. Masui. 2009;58(1):34-9.
- Rumgay H, Murphy N, Ferrari P, Soerjomataram I. Alcohol and cancer: Epidemiology and biological mechanisms. Nutrients. 2021;13(9):3173.
- Diamond I, Messing RO. Neurologic effects of alcoholism. West J Med. 1994;161(3):279-87.
- Chikritzhs T, Livingston M. Alcohol and the risk of injury. Nutrients. 2021;13(8):2777.
- Smaga A, Bogusławski S, Wróbel K, Wojtyniak B. Rozpowszechnienie behawioralnych czynników ryzyka zdrowotnego i jego zmiany w okresie pandemii COVID-19. In: Wojtyniak B, Goryński P (eds.). Sytuacja zdrowotna ludności Polski i jej uwarunkowania 2022. Warszawa: Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy; 2022.
- Barbería-Latasa M, Gea A, Martínez-González MA. Alcohol, drinking pattern, and chronic disease. Nutrients. 2022;14(9):1954.
- Maillot F, Farad S, Lamisse F. Alcohol and nutrition. Pathol Biol (Paris). 2001;49(9):683-8.
- de los Santos AR, Di Girolamo G, Martí ML. Efficacy and tolerance of lysine clonixinate versus paracetamol/codeine following inguinal hernioplasty. Int J Tissue React. 1998;20(2):71-81.
- Ketonal Sprint, Characteristics of the Medicinal Product. [https://product-documents/doc144060/ketonal-sprint-dokument.pdf]. (access: 10.12.2023).
- Nunes AP, Costa IM, Costa FA. Determinants of self-medication with NSAIDs in a Portuguese community pharmacy. Pharm Pract (Granada). 2016;14(1):648.
- Fang F, Lu Y, Ma DL, Du TT, Shao SY, Yu XF. A meta-analysis of salicylates for type 2 diabetes mellitus. J Huazhong Univ Sci Technolog Med Sci. 2013;33(1):1-14.
- van de Wiel A. Diabetes mellitus and alcohol. Diabetes Metab Res Rev. 2004;20(4):263-7.
- Tian F, Zhang YJ, Li Y, Xie Y. Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression. PLoS One. 2014;9(1):e83819.
- Huang LL, Xia HH, Zhu SL. Ascitic fluid analysis in the differential diagnosis of ascites: Focus on Cirrhotic ascites. J Clin Transl Hepatol. 2014;2(1):58-64.
- Woroń J. Ketoprofen with lysine in pain pharmacotherapy, or how can I effectively improve the effectiveness and safety of known NSAID? Lekarz POZ. 2019;5(5):389-94.
- Kuczyńska J, Nieradko-Iwanicka B. Comparison of the effects of ketoprofen and ketoprofen lysine salt on the Wistar rats’ nervous system, kidneys and liver after ethyl alcohol intoxication. Biomed Pharmacother. 2023;161:114456.
- Paquot N. Le métabolisme de l’alcool. Rev Med Liege. 2019; 74(5-6):265-7.